Beta-thalassemia major (β-TM) is a severe form of thalassemia caused by mutations in the β-globin gene, resulting in partial or complete deficiency of β-globin chains. This deficiency results in oxidative stress, dyserythropoiesis, and chronic anemia. Cytokine dependent hematopoietic cell linker (CLNK) belongs to the adaptor protein family and has the capacity to interact with multiple signaling proteins thereby modulating signal transduction.
Introduction
Beta-thalassemia major (β-TM), a hereditary anemia characterized by absent or decreased production of β-globin chains, is associated with considerable morbidity and mortality. 1 These patients are treated with continuous administration of blood transfusion to raise the depletion of red blood cells (RBCs). 2 The treatment regimen causes iron overload whereby excess iron accumulates in the body organs tissues such as heart, liver and endocrine glands causing damage to the organs. 3, 4 Eryptosis (suicidal erythrocyte death) contributes to or even accounts for the anemia in β-TM, and involves Ca 2+ entry and ceramide, caspase, and tyrosine kinase signaling.
Inhibitors of eryptosis may prevent anemia in clinical conditions associated with enhanced eryptosis. 5 Fetal hemoglobin (HbF), which consists of two γ-globin chains and two α-chains, is normally replaced by adult hemoglobin (HbA) at birth, whilst in β-TM, γ-chain production continues into adulthood. 6 In patients with β-TM, cAMP levels are elevated in both red blood cells and nucleated erythroblasts and the transcription factor cAMP response element binding protein is phosphorylated in nucleated erythroblasts, while its phosphorylation levels correlate with HBG mRNA levels of the patients. 7 Many signaling molecules, such as mitogen-activated protein kinases and signal transducers and activators of transcription proteins, are phosphorylated at variable levels. 7, 8 Plasma levels of cytokines, such as erythropoietin, stem cell factor and transforming growth factor-β are increased in β-TM patients, and these cytokines induce both γ-globin gene (HBG) mRNA expression and cAMP response element binding protein phosphorylation. 7 The Src family of protein tyrosine kinases (SFKs) is a family of non-receptor tyrosine kinases which play a central role in the regulation of hematopoietic cell functions and is are involved in regulation of membrane transport. 9 SFKs play a key role in regulating signal transduction by a diverse set of cell surface receptors. SFKs exhibit many molecular strategies to couple receptors with the cytoplasmic signaling machinery. 10 Src-family kinases are implicated in regulation of erythrocyte membrane cation transport including tyrosine phosphorylation regulating K/Cl cotransport. 15, 16, 17 Nevertheless, no studies have examined CLNK in β-TM patients.
Hence, the present study examines serum levels of CLNK in β-TM patients as compared with healthy controls and the associations between CLNK levels and serum iron status. The specific hypothesis is that serum CLNK is significantly increased in β-TM children.
Subjects and Methods

Subjects
Sixty β-TM patients aged 3-12 years participated in the present study. All of them were on blood transfusion regimen in the Thalassemia Unit at "Al-Zahra'a Teaching Hospital" in Serological serum CRP was negative in all samples i.e. less than 6mg/L. CRP test was used to exclude inflammation that causes changes in the acute phase reactant proteins. 19 None of the patients had undergone splenectomy. Endocrinologic, hepatologic and cardiac evaluations were regularly performed and showed normal results at the time of sample collection. Blood samples from patients were collected 7-10 days after the last transfusion and just before the next transfusion. Only patients who are free from any other systemic disease were participated in the study. Thirty apparently healthy children were carefully chosen as the control group. Their age range and mean were comparable to that of patients. None of the controls was anaemic or had any obvious systemic or hematological diseases. shows that the required sample size is 90 participants. We computed two z unit weighted composite scores containing Ln(CLNK) namely, zLn(CLNK)+zLn(Ferritin) and zLn(CLNK)+zLn(Ferritin)+zLn(Iron)). Receiver operating characteristic (ROC) curves were utilized to determine the sensitivity and specificity of the outcome variables to differentiate between patients and controls. The bootstrapped (n-=2000) Area Under the Curve (AUC) was calculated to determine the diagnostic accuracy for β-TM. An optimal diagnostic tool has an AUC of 1, which indicates 100% sensitivity and specificity. 21 Tests were 2-tailed and a p-value of 0.05 was used for statistical significance. All statistical analyses were performed using IBM SPSS windows version 25, 2017.
Results Table 1 presents the socio-demographic, clinical data, iron status parameters, as well as CLNK and the composite scores in β-TM patients and controls. There were no significant differences in the sex ratio between the both categories, while age was somewhat higher in controls than in patients (without p-correction). Hb and PCV were significantly lower in β-TM as compared with controls. Serum iron, TS%, ferritin, and EIBC were significantly higher in β-TM than in controls. CLNK and the CLNK-containing composite scores were significantly higher in patients as compatred with healthy controls. In the total study group, we found significant correlations between CLNK and Hb (p=-0.341, p=0.001), PCV% (p=-0.338, p=0.001), ferritin (p=0.452, p<0.001), but not iron or transferrin. In β-TM there was a significant association between CLNK and number of transfusions (p=0.305, p=0.018). Table 2 displays the results of a multivariate GLM analysis with CLNK and the zCLNK+zFerritin+zIron composite score as dependent variables and with diagnosis as primary explanatory variable, while we adjusted for possible age and sex effects. There was a highly significant effect of diagnosis with an effect size of 0.635, while age and sex had no significant effect on the biomarkers. Tests for betwee-subject analyses showed that there are strong associations between diagnosis and both CLNK and the composite score. We also performed an univariate analysis with CLNK as dependent variable and found that the significant effects of diagnosis were no longer significant after inducing ferritin in the analysis. The last univariate analysis in Table shows that 20.4% of the variance in CLNK was explained by ferritin.
The results of ROC analysis including AUC are presented in Table 3 . The bootstrapped area under the ROC curve was 0.738 for CLNK while that of ferritin was 0.978. Combining CLNK with ferritin and / or iron did not improve the diagnostic performance of ferritin.
Discussion
The major finding of this study is that CLNK and the CLNK-containing composite scores showed a highly significant increase in patients as compatred with healthy controls. Moreover, the increased levels of CLNK were explained at least in part by increased levels of ferritin. The increased CLNK levels in β-TM patients may be explained by reciprocal effects of aberrant and is expressed in cytokine-activated hematopoietic cells including mast cells and NK cells.
11,22
As other family members, CLNK contains 3 protein interaction domains, including amino terminus tyrosine residues, which are phosphorylated by Src family PTKs and also Syk. 23 The SLP-76-related adaptor molecule CLNK physically and functionally interacts with HPK-1 in immunoreceptor-activated hemopoietic cells. CLNK has the capacity to substitute at least partially for SLP-76 during immunoreceptor signaling, even though it binds to a distinct set of partners.
14 The pathophysiological mechanisms of ineffective erythropoiesis in β-TM could be the result of several mechanisms of which the final consequence is the arrest of maturation and increased apoptosis of erythroblasts during their terminal differentiation stage. 25 CLNK can function as a signaling scaffold downstream of multiple immune receptors. 14, 22, 23 Other findings on the transcriptional regulation of the CLNK gene helps to understand how lineage-specific immunoreceptor signaling pathways are established and regulated during activation and differentiation of various hematopoietic cells. 24 Increased level of several inflammatory cytokines has been reported in β-TM and may contribute to ineffective erythropoiesis, through anemia associated with chronic disease. 25 Our results also showed the typical picture of iron overload state and anemia in β-TM, including higher serum iron, TS%, ferritin, and EIBC and lower Hb and PCV in β-TM as compared with controls. Our findings are in accordance with Kuldeep et al., (2011) 26 who found a significant increase in serum iron in patients with β-TM as compared with healthy controls.
These results are also in accordance with those of previous studies. 3, 27 The predominant mechanism driving the iron loading process includes transfusion therapy and enhanced intestinal absorption secondary to ineffective erythropoiesis. 2 Serum ferritin measurement and noninvasive imaging techniques are available to diagnose iron overload, quantify its extent in different organs, and monitor clinical response to therapy. 2 Higher levels of serum ferritin (especially over 2500 µg/l) are associated with iron-related organ failure particularly in the liver and heart. 27 This organ damage is not only related to oxidative stress end products, 18 but also to the direct effect of iron overload on the tissues. In the current study, serum CLNK was significantly associated with number of transfusions, ferritin and iron. The overall positive correlation between CLNK and iron status parameters such as ferritin indicates the dependence of the CLNK level on iron overload status. In patients with transfusion-dependent β-TM, red blood cell transfusion is the mainstream management although regular blood transfusions may cause iron overload leading to organ damage. 28 A positive association between duration of blood transfusion and degree of body iron was observed previously. 29 Furthermore, some studies reported positive correlations between serum ferritin and duration of transfusion and age of the patients. Hb expression in β-TM. 7 Hemoglobinopathies such as sickle cell disease and thalassemia are accompanied by a substantial increase in microvesicle levels. 16, 30 33 These factors may underpin the associations among CLNK and RBCs, which undergo hemolysis in β-TM patients.
Limitations of the study
The limitation of the study was the smaller sample size. Therefore, it is considered a pilot study and further studies on a larger cohorts are warranted.
Conclusion
In the present study we introduced a new biomarker (CLNK) to diagnose β-TM and iron overload in β-TM. The serum CLNK concentrations are higher in thalassemic patients as compared with controls. CLNK level depends on number of transfusion, Hb, ferritin, and iron.
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